SSX7 anticorps (N-Term)

N° du produit ABIN1881839

Il existe 2+ publications pour ce produit. L’anticorps anti-SSX7 Polyclonal Lapin est utilisé pour la détection de SSX7 dans des échantillons de Humain. Il a été validé pour WB.

Aperçu rapide pour SSX7 anticorps (N-Term) (ABIN1881839)

Antigène: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SSX7 est non-conjugé

Application: Western Blotting (WB)

Clone: RB41797

Détail du produit anti-SSX7 anticorps

Épitope: AA 1-30, N-Term

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This SSX7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human SSX7.

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Date de péremption: 6 months

Références pour anticorps anti-SSX7 (ABIN1881839)

Güre, Wei, Old, Chen: "The SSX gene family: characterization of 9 complete genes." dans: International journal of cancer. Journal international du cancer, Vol. 101, Issue 5, pp. 448-53, (2002) (PubMed).

Chen, Chen, Lee, Huang, Yang, Tsai, Chen, Sheu: "Expressions of cancer-testis antigens in human hepatocellular carcinomas." dans: Cancer letters, Vol. 164, Issue 2, pp. 189-95, (2001) (PubMed).

Détails sur SSX7

Antigène: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Autre désignation: SSX7

Sujet: The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This gene appears not to be involved in this type of chromosome translocation.

Poids moléculaire: 21591

NCBI Accession: NP_775494

UniProt: Q7RTT5